Zuo W - Search Results

1

[Expression of osteopontin splice variant and its clinical significance in gastric cancer].

Sun X, Wang L, Hou W, Li Y, Liu L, Zuo W, Yu J. Sun X, et al. Among authors: zuo w. Zhonghua Zhong Liu Za Zhi. 2015 Jun;37(6):427-30. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26463145 Chinese.

2

[Expression of CD80, CD86, TGF-beta1 and IL-10 mRNA in the esophageal carcinoma].

Yang WF, Yu JM, Zuo WS, Wang SZ. Yang WF, et al. Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):762-5. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17366789 Chinese.

3

[Expression of osteopontin mRNA and its clinical significance in gastric cancer].

Sun XJ, Zuo WS, Ma H, Hou WH, Cai SP, Jiang XH. Sun XJ, et al. Zhonghua Zhong Liu Za Zhi. 2005 May;27(5):292-5. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 15996323 Chinese.

4

miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.

Fu H, Fu L, Xie C, Zuo WS, Liu YS, Zheng MZ, Yu JM. Fu H, et al. Oncol Rep. 2017 Feb;37(2):1093-1099. doi: 10.3892/or.2017.5360. Epub 2017 Jan 9. Oncol Rep. 2017. PMID: 28075453

5

[Clinical significance of sentinel lymph node biopsy for breast cancer].

Zuo W, Wang Y, Li M. Zuo W, et al. Zhonghua Zhong Liu Za Zhi. 2001 May;23(3):247-50. Zhonghua Zhong Liu Za Zhi. 2001. PMID: 11783099 Chinese.

6

[Flow cytometric quantitative analysis of multiple tumor suppressor gene 1 (MTS1) and cyclooxygenase-2 (COX-2) gene expressions in invasive breast cancers and their clinical significance].

Zuo WS, Wei L, Wang XW, Wang YS, Yu ZY, Bi Y, Liu YS, Zhou ZB. Zuo WS, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):515-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17147116 Chinese.

7

[Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].

Wei L, Song XR, Wang XW, Li M, Z uo WS. Wei L, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):445-8. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17152492 Chinese.

8

Preoperative lymphoscintigraphy predicts the successful identification but is not necessary in sentinel lymph nodes biopsy in breast cancer.

Wang L, Yu JM, Wang YS, Zuo WS, Gao Y, Fan J, Li JY, Hu XD, Chen ML, Yang GR, Zhou ZB, Liu YS, Li YQ, Liu YB, Zhao T, Chen P. Wang L, et al. Ann Surg Oncol. 2007 Aug;14(8):2215-20. doi: 10.1245/s10434-007-9418-4. Epub 2007 May 24. Ann Surg Oncol. 2007. PMID: 17522946

9

[Analysis of clinicopathological factors associated with false-negative rate of sentinel lymph node biopsy in breast cancer patients: experience of a single center].

Yang B, Zheng G, Zuo WS, Yang L, Wang YS, Zheng MZ, Liu YS, Yu ZY. Yang B, et al. Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):389-93. doi: 10.3760/cma.j.issn.0253-3766.2013.05.015. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24054019 Chinese.

10

[Expressions of Fas, CTLA-4 and RhoBTB2 genes in breast carcinoma and their relationship with clinicopathological factors].

Bi Y, Wei L, Mao HT, Zhang L, Zuo WS. Bi Y, et al. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):749-53. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173804 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,311 results

Search Page

Filters